XM does not provide services to residents of the United States of America.

South Korea drops plan to suspend licenses of striking doctors



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>South Korea drops plan to suspend licenses of striking doctors</title></head><body>

By Ju-min Park

SEOUL, July 8 (Reuters) -South Korea said on Monday it would drop a plan to suspend the licenses of striking trainee doctors, offering a concession to end a months-long walkout prompted by the government's decision to increase medical school admissions.

Thousands of trainee doctors, which include medical interns and resident doctors, walked off the job in February, forcing major hospitals to cut back non-emergency services and turn back patients at emergency rooms.

Health Minister Cho Kyoo-hong said the government had decided not to suspend the licenses of the striking doctors, whether they return to work or not.

Cho said the decision to drop its threat of punitive action was necessary because ending the current shortage in medical services is "more urgent".

Two-thirds of the country's residents and intern doctors have walked off the job to protest a plan to raise the number of students admitted to medical school each year by 2,000 in a bid to address what the government says is a shortage of doctors.

The young doctors who are protesting say the government should first address pay and working conditions before trying to increase the number of physicians.

Cho added that the government would build a "sustainable" medical system that does not rely on excessive work by trainee doctors.

"Trainee doctors, do not hesitate any longer, and take out courage to decide. The government will make sure you, our previous resources who have chosen essential medical care evenunder difficult circumstances, can focus on training without worry,"Cho said at a briefing.

The minister also called on the trainee doctors to return and join dialogue to discuss their working conditions as well as the medical college admission quota for 2026 and beyond.



Reporting by Ju-min Park; Editing by Sharon Singleton

</body></html>

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.